Amyloid-β oligomers in cellular models of Alzheimer’s disease

NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537 · see citing works

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · see citing works

Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Greene, L., & Tischler, A. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.7.2424 · Cited by 5,594 · see citing works

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431 · see citing works

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396 · see citing works

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · see citing works

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

Mccarthy, K., & de Vellis, J. (1980) · Journal of Cell Biology · doi:10.1083/jcb.85.3.890 · Cited by 3,915 · see citing works

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · see citing works

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204 · see citing works

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059 · see citing works

Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate

Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534 · see citing works

Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)

Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., & Tada, K. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910260208 · Cited by 2,258 · see citing works

2018 Alzheimer's disease facts and figures

Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912 · see citing works

Culturing hippocampal neurons

Kaech, S., & Banker, G. A. (2006) · Nature Protocols · doi:10.1038/nprot.2006.356 · Cited by 1,705 · see citing works

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers

Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560 · see citing works

Uber eine eigenartige Erkrankung der Hirnrinde

Alzheimer, A. (1907) · Medical Entomology and Zoology · Cited by 1,503 · see citing works

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417 · see citing works

Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice

Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · see citing works

Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Biedler, J. L., Helson, L., & Spengler, B. A. (1973) · PubMed · Cited by 1,295 · see citing works

Diversity of astrocyte functions and phenotypes in neural circuits

Khakh, B. S., & Sofroniew, M. V. (2015) · Nature Neuroscience · doi:10.1038/nn.4043 · Cited by 1,239 · see citing works

Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance

Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,227 · see citing works

Astrocyte glutamate transport: Review of properties, regulation, and physiological functions

Anderson, C. M., & Swanson, R. A. (2000) · Glia · doi:10.1002/1098-1136(200010)32:1 · Cited by 1,218 · see citing works

The GSK3 hypothesis of Alzheimer’s disease

Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191 · see citing works

Culturing hippocampal neurons.

Tanaka, H. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.119.163 · Cited by 1,141 · see citing works

APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types

Lin, Y.-T., Seo, J., Gao, F., Feldman, H. M., Wen, H.-L., Penney, J., Cam, H. P., Gjoneska, E., Raja, W. K., Cheng, J., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.008 · Cited by 1,125 · see citing works

Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils

Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., & Smith, S. O. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1799 · Cited by 1,111 · see citing works

Rat hippocampal neurons in dispersed cell culture.

Banker, G. A., & Cowan, W. M. (1977) · Brain Research · doi:10.1016/0006-8993(77)90594-7 · Cited by 1,110 · see citing works

The SH-SY5Y cell line in Parkinson’s disease research: a systematic review

Xicoy, H., Wieringa, B., & Martens, G. J. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0149-0 · Cited by 1,036 · see citing works

In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis

Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015 · see citing works

Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014 · see citing works

Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake

Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972 · see citing works

Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease

Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971 · see citing works

Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models

Lourenco, M. V., Frozza, R. L., de Freitas, G. B., Zhang, H., Kincheski, G. C., Ribeiro, F. C., Gonçalves, R. A., Clarke, J. R., Beckman, D., Staniszewski, A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0275-4 · Cited by 935 · see citing works

Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease

Mosconi, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1762-7 · Cited by 900 · see citing works

Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine

De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882 · see citing works

Glia — more than just brain glue

Allen, N. J., & Barres, B. A. (2009) · Nature · doi:10.1038/457675a · Cited by 856 · see citing works

In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity

Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)91553-d · Cited by 829 · see citing works

Modeling Alzheimer’s Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular Aβ and Differential Drug Responsiveness

Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741 · see citing works

Processing of the Amyloid Protein Precursor to Potentially Amyloidogenic Derivatives

Golde, T. E., Estus, S., Younkin, L. H., Selkoe, D. J., & Younkin, S. G. (1992) · Science · doi:10.1126/science.1738847 · Cited by 737 · see citing works

Intraneuronal Alzheimer Aβ42 Accumulates in Multivesicular Bodies and Is Associated with Synaptic Pathology

Takahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., Beal, M. F., Xu, H., Greengard, P., & Gouras, G. K. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64463-x · Cited by 706 · see citing works

Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers

De Felice, F. G., Vieira, M. N. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., Viola, K. L., Zhao, W.-Q., Ferreira, S. T., & Klein, W. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809158106 · Cited by 657 · see citing works

Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons

Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A. O., Wısnıewskı, T., Gunther, E. C., & Strittmatter, S. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3178 · Cited by 654 · see citing works

A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease

Park, J., Wetzel, I., Marriott, I., Dréau, D., D’Avanzo, C., Kim, D. Y., Tanzi, R. E., & Cho, H. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0175-4 · Cited by 644 · see citing works

Galectins at a glance

Johannes, L., Jacob, R., & Leffler, H. (2018) · Journal of Cell Science · doi:10.1242/jcs.208884 · Cited by 631 · see citing works

β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase

Abramov, A. Y., Canevari, L., & Duchen, M. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4042-03.2004 · Cited by 587 · see citing works

Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein

Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572 · see citing works

ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions

Verghese, P. B., Castellano, J. M., Garai, K., Wang, Y., Jiang, H., Shah, A., Bu, G., Frieden, C., & Holtzman, D. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220484110 · Cited by 556 · see citing works

ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion

Huang, Y.-W. A., Zhou, B., Wernig, M., & Südhof, T. C. (2017) · Cell · doi:10.1016/j.cell.2016.12.044 · Cited by 528 · see citing works

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Sardar Sinha, M., Ansell-Schultz, A., Civitelli, L., Hildesjö, C., Larsson, M., Lannfelt, L., Ingelsson, M., & Hallbeck, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1868-1 · Cited by 527 · see citing works

The Oligomerization of Amyloid β-Protein Begins Intracellularly in Cells Derived from Human Brain

Walsh, D. M., Tseng, B. P., Rydel, R. E., Podlisny, M. B., & Selkoe, D. J. (2000) · Biochemistry · doi:10.1021/bi001048s · Cited by 502 · see citing works

An In Vitro Model for Neuroscience: Differentiation of SH-SY5Y Cells into Cells with Morphological and Biochemical Characteristics of Mature Neurons

Agholme, L., Lindström, T., Kågedal, K., Marcusson, J. O., & Hallbeck, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091363 · Cited by 500 · see citing works

Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5

Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., & Triller, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.029 · Cited by 468 · see citing works

Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease

Joachim, C. L., Mori, H., & Selkoe, D. J. (1989) · Nature · doi:10.1038/341226a0 · Cited by 462 · see citing works

A POST-MORTEM STUDY OF THE CHOLINERGIC AND GABA SYSTEMS IN SENILE DEMENTIA

Rossor, M. N., Garrett, N., Johnson, A. L., Mountjoy, C. Q., Roth, M., & Iversen, L. L. (1982) · Brain · doi:10.1093/brain/105.2.313 · Cited by 460 · see citing works

The probability of neurotransmitter release: variability and feedback control at single synapses

Branco, T., & Staras, K. (2009) · Nature reviews. Neuroscience · doi:10.1038/nrn2634 · Cited by 445 · see citing works

Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo

Lindholm, P., Voutilainen, M. H., Laurén, J., Peränen, J., Leppänen, V., Andressoo, J., Lindahl, M., Janhunen, S. K., Kalkkinen, N., Timmusk, T., et al. (2007) · Nature · doi:10.1038/nature05957 · Cited by 444 · see citing works

TNF-α Mediates PKR-Dependent Memory Impairment and Brain IRS-1 Inhibition Induced by Alzheimer’s β-Amyloid Oligomers in Mice and Monkeys

Lourenco, M. V., Clarke, J. R., Frozza, R. L., Bomfim, T. R., Forny‐Germano, L., Batista, A. F., Sathler, L. B., Brito‐Moreira, J., Amaral, O. B., Silva, C. A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.002 · Cited by 415 · see citing works

Functions and mechanisms of retrograde neurotrophin signalling

Zweifel, L. S., Kuruvilla, R., & Ginty, D. D. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1727 · Cited by 413 · see citing works

Glial cells in the enteric nervous system contain glial fibrillary acidic protein

Jessen, K. R., & Mirsky, R. (1980) · Nature · doi:10.1038/286736a0 · Cited by 406 · see citing works

Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion

Verkhratsky, A., Matteoli, M., Parpura, V., Mothet, J., & Zorec, R. (2016) · The EMBO Journal · doi:10.15252/embj.201592705 · Cited by 397 · see citing works

Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice

Cui, G., Wu, J., Mou, F., Xie, W., Wang, F., Wang, Q., Fang, J., Xu, Y., Dong, Y., Liu, J., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700600r · Cited by 387 · see citing works

Amyloid β oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors

Alberdi, E. M., Sánchez‐Gómez, M. V., Cavaliere, F., Pérez‐Samartín, A., Zugaza, J. L., Trullás, R., Domercq, M., & Matute, C. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.010 · Cited by 364 · see citing works

Aggregation of Secreted Amyloid β-Protein into Sodium Dodecyl Sulfate-stable Oligomers in Cell Culture

Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydel, R. E., Teplow, D. B., & Selkoe, D. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9564 · Cited by 364 · see citing works

Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology

Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J. V., Lin, A. H., Crews, L., Tremblay, P., Mathews, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27341 · Cited by 355 · see citing works

Astrocyte Biomarkers in Alzheimer’s Disease

Carter, S. F., Herholz, K., Rosa-Neto, P., Pellerin, L., Nordberg, A., & Zimmer, E. R. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.11.006 · Cited by 355 · cited 1× · see citing works

Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

Ferreira, S. T., Clarke, J. R., Bomfim, T. R., & Felice, F. G. D. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.010 · Cited by 354 · see citing works

The Dynamic Landscape of Open Chromatin during Human Cortical Neurogenesis

de la Torre-Ubieta, L., Stein, J. L., Won, H., Opland, C. K., Liang, D., Lu, D., & Geschwind, D. H. (2018) · Cell · doi:10.1016/j.cell.2017.12.014 · Cited by 353 · see citing works

Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies

Lambert, M. P., Viola, K. L., Chromy, B. A., Chang, L., Morgan, T. E., Yu, J., Venton, D. L., Krafft, G. A., Finch, C. E., & Klein, W. L. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00592.x · Cited by 349 · see citing works

Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures

Das, K. P., Freudenrich, T. M., & Mundy, W. R. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.02.006 · Cited by 328 · see citing works

16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer’s Post-Mortem Brain

Emery, D. C., Shoemark, D. K., Batstone, T. E., Waterfall, C. M., Coghill, J. A., Cerajewska, T. L., Davies, M., West, N. X., & Allen, S. J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00195 · Cited by 317 · see citing works

Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia

Sondag, C. M., Dhawan, G., & Combs, C. K. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-1 · Cited by 295 · see citing works

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity

Izzo, N. J., Xu, J., Zeng, C., Kirk, M. J., Mozzoni, K., Silky, C., Rehak, C., Yurko, R., Look, G. C., Rishton, G. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111899 · Cited by 294 · see citing works

Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology

Revett, T. J., Baker, G. B., Jhamandas, J. H., & Kar, S. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110190 · Cited by 294 · see citing works

Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins

Xia, W., Zhang, J., Kholodenko, D., Citron, M., Podlisny, M. B., Teplow, D. B., Haass, C., Seubert, P. A., Koo, E. H., & Selkoe, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7977 · Cited by 282 · see citing works

Differentiation of mouse Neuro 2A cells into dopamine neurons

Tremblay, R. G., Sikorska, M., Sandhu, J. K., Lanthier, P. H., Ribecco‐Lutkiewicz, M., & Bani‐Yaghoub, M. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.11.004 · Cited by 280 · see citing works

The Pathophysiological Role of Microglia in Dynamic Surveillance, Phagocytosis and Structural Remodeling of the Developing CNS

Arcuri, C., Mecca, C., Bianchi, R., Giambanco, I., & Donato, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00191 · Cited by 279 · see citing works

Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures

Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(91)90014-9 · Cited by 276 · see citing works

Rapid nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex

Watson, F. L., Heerssen, H. M., Moheban, D. B., Lin, M. Z., Sauvageot, C. M., Bhattacharyya, A., Pomeroy, S. L., & Segal, R. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-07889.1999 · Cited by 272 · see citing works

Neurotrophin signalling: novel insights into mechanisms and pathophysiology

Mitre, M., Mariga, A., & Chao, M. V. (2017) · Clinical Science · doi:10.1042/cs20160044 · Cited by 263 · see citing works

Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies.

Shafer, T. J., & Atchison, W. D. (1991) · PubMed · Cited by 252 · see citing works

Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptors

Rönicke, R., Mikhaylova, M., Rönicke, S., Meinhardt, J., Schröder, U. H., Fändrich, M., Reiser, G., Kreutz, M. R., & Reymann, K. G. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.011 · Cited by 246 · see citing works

Cellular Functions of the Amyloid Precursor Protein from Development to Dementia

van der Kant, R., & Goldstein, L. S. B. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.022 · Cited by 246 · see citing works

The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non‐human primate model of Alzheimer's disease

Batista, A. F., Forny‐Germano, L., Clarke, J. R., Silva, N. M. L. E., Brito‐Moreira, J., Boehnke, S. E., Winterborn, A., Coe, B. C., Lablans, A., Vital, J. F. S., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5056 · Cited by 246 · see citing works

Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes

Habchi, J., Chia, S., Galvagnion, C., Michaels, T. C. T., Bellaiche, M. M. J., Ruggeri, F. S., Sanguanini, M., Idini, I., Kumita, J. R., Sparr, E., et al. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0031-x · Cited by 245 · see citing works

Neurogenic Effect of  -Amyloid Peptide in the Development of Neural Stem Cells

Lopez-Toledano, M. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0974-04.2004 · Cited by 241 · see citing works

Hydrogen Peroxide Is Generated during the Very Early Stages of Aggregation of the Amyloid Peptides Implicated in Alzheimer Disease and Familial British Dementia

Tabner, B. J., El‐Agnaf, O. M. A., Turnbull, S., German, M. J., Paleologou, K. E., Hayashi, Y., Cooper, L. J., Fullwood, N. J., & Allsop, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500238200 · Cited by 241 · see citing works

Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: Involvement of endoplasmic reticulum calcium release in oligomer-induced cell death

Resende, R., Ferreiro, E., Pereira, C., & Resende de Oliveira, C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.036 · Cited by 235 · see citing works

d-serine levels in Alzheimer’s disease: implications for novel biomarker development

Madeira, C., Lourenco, M. V., Vargas-Lopes, C., Suemoto, C. K., Brandão, C. O., Reis, T., Leite, R. E. P., Laks, J., Jacob-Filho, W., Pasqualucci, C. A., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.52 · Cited by 233 · see citing works

Early Oligodendrocyte/Myelin Pathology in Alzheimer's Disease Mice Constitutes a Novel Therapeutic Target

Desai, M. K., Mastrangelo, M. A., Ryan, D. A., Sudol, K. L., Narrow, W. C., & Bowers, W. J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100087 · Cited by 232 · see citing works

Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes

Xu, J., Chen, S., Ahmed, S. H., Chen, H., Ku, G., Goldberg, M. P., & Hsu, C. Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0001.2001 · Cited by 230 · see citing works

The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury

Vafeiadou, K., Vauzour, D., Lee, H. Y., Rodriguez‐Mateos, A., Williams, R. J., & Spencer, J. P. E. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.01.016 · Cited by 224 · see citing works

Amyloid- Peptide Oligomers Disrupt Axonal Transport through an NMDA Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase Kinase 3 in Primary Cultured Hippocampal Neurons

Decker, H., Lo, K. Y., Unger, S. M., Ferreira, S. T., & Silverman, M. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1074-10.2010 · Cited by 216 · see citing works

The Non-Amyloidogenic Pathway: Structure and Function of α-Secretases

Kojro, E., & Fahrenholz, F. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_5 · Cited by 211 · see citing works

Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins

Huynh, T.-P. V., Davis, A. A., Ulrich, J. D., & Holtzman, D. M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075481 · Cited by 210 · see citing works

APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types

Lin, Y.-T., Seo, J., Gao, F., Feldman, H. M., Wen, H.-L., Penney, J., Cam, H. P., Gjoneska, E., Raja, W. K., Cheng, J., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.011 · Cited by 210 · see citing works

Systemic Catabolism of Alzheimer's Aβ40 and Aβ42

Ghiso, J., Shayo, M., Calero, M., Ng, D., Tomidokoro, Y., Gandy, S., Rostagno, A., & Frangione, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407668200 · Cited by 209 · see citing works

Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer’s Disease?

Fülöp, T., Witkowski, J. M., Bourgade, K., Khalil, A., Zerif, E., Larbi, A., Hirokawa, K., Pawelec, G., Bocti, C., Lacombe, G., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00224 · Cited by 201 · see citing works

β-Amyloid impairs axonal BDNF retrograde trafficking

Poon, W. W., Blurton-Jones, M. M., Tu, C. H., Feinberg, L. M., Chabrier, M. A., Harris, J. W., Jeon, N. L., & Cotman, C. W. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.012 · Cited by 198 · see citing works

Conformations and Biological Activities of Amyloid Beta Peptide 25-35

Millucci, L., Ghezzi, L., Bernardini, G., & Santucci, A. (2010) · Current Protein and Peptide Science · doi:10.2174/138920310790274626 · Cited by 195 · see citing works

Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts

Gralle, M., & Ferreira, S. T. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.02.001 · Cited by 191 · see citing works

The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects

Wießner, C., Wiederhold, K., Tissot, A. C., Frey, P., Danner, S., Jacobson, L. H., Jennings, G. T., Lüönd, R. M., Ortmann, R., Reichwald, J., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0293-11.2011 · Cited by 190 · see citing works

Ca2+‐dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid β‐treated astrocytes and in a model of A lzheimer's disease

Alberdi, E. M., Wyssenbach, A., Alberdi, M., Sánchez‐Gómez, M. V., Cavaliere, F., Rodriguez, J. J., Verkhratsky, A., & Matute, C. (2013) · Aging Cell · doi:10.1111/acel.12054 · Cited by 188 · see citing works

Nature of the Amyloid-β Monomer and the Monomer-Oligomer Equilibrium

Nag, S., Sarkar, B., Bandyopadhyay, A., Sahoo, B., Sreenivasan, V. K. A., Kombrabail, M. H., Chandrakesan, M., & Maiti, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199885 · Cited by 186 · see citing works

Oligomerization of Endogenous and Synthetic Amyloid β-Protein at Nanomolar Levels in Cell Culture and Stabilization of Monomer by Congo Red

Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., & Selkoe, D. J. (1998) · Biochemistry · doi:10.1021/bi972029u · Cited by 186 · see citing works

Amyloid beta peptide 1–42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures

Ferreira, I. L., Bajouco, M., Mota, S. I., Auberson, Y. P., Oliveira, C. R., & Rego, A. C. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.11.008 · Cited by 185 · see citing works

Memantine Rescues Transient Cognitive Impairment Caused by High-Molecular-Weight A Oligomers But Not the Persistent Impairment Induced by Low-Molecular-Weight Oligomers

Figueiredo, C. P., Clarke, J. R., Ledo, J. H., Ribeiro, F. C., Costa, C., Melo, H. M., Mota-Sales, A. P., Saraiva, L. M., Klein, W. L., Sebollela, A. S., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0482-13.2013 · Cited by 181 · see citing works

Neprilysin-sensitive Synapse-associated Amyloid-β Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function

Huang, S.-M., Mouri, A., Kokubo, H., Nakajima, R., Suemoto, T., Higuchi, M., Staufenbiel, M., Noda, Y., Yamaguchi, H., Nabeshima, T., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601372200 · Cited by 179 · see citing works

Degradation of Amyloid β-Protein by a Metalloprotease Secreted by Microglia and Other Neural and Non-neural Cells

Qiu, W. Q., Ye, Z., Kholodenko, D., Seubert, P. A., & Selkoe, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6641 · Cited by 175 · see citing works

How factors secreted from astrocytes impact myelin repair

Moore, C. S., Abdullah, S. L., Brown, A. D., Arulpragasam, A. R., & Crocker, S. J. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22482 · Cited by 172 · see citing works

A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons

Zhang, D., Pekkanen-Mattila, M., Shahsavani, M., Falk, A., Teixeira, A. I., & Herland, A. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.028 · Cited by 171 · see citing works

Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model

Pereira Diniz, L., Tortelli, V., Matias, I., Morgado, J., Bérgamo Araujo, A. P., Melo, H. M., Seixas da Silva, G. S., Alves-Leon, S. V., de Souza, J. M., Ferreira, S. T., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3351-16.2017 · Cited by 171 · see citing works

Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination

Samanta, J., Grund, E. M., Silva, H. M., Lafaille, J. J., Fishell, G., & Salzer, J. L. (2015) · Nature · doi:10.1038/nature14957 · Cited by 170 · see citing works

Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead

Kumar, D., Ganeshpurkar, A., Kumar, D., Modi, G. P., Gupta, S., & Singh, S. K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.035 · Cited by 170 · see citing works

Subcellular Topography of Neuronal Aβ Peptide in APPxPS1 Transgenic Mice

Langui, D., Girardot, N., El Hachimi, K. H., Allinquant, B., Blanchard, V., Pradier, L., & Duyckaerts, C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63405-0 · Cited by 165 · see citing works

Cell Engineering and Cultivation of Chinese Hamster Ovary (CHO) Cells

Ōmasa, T., Onitsuka, M., & Kim, W.-D. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110791111960 · Cited by 165 · see citing works

Levels of Soluble Apolipoprotein E/Amyloid-β (Aβ) Complex Are Reduced and Oligomeric Aβ Increased with APOE4 and Alzheimer Disease in a Transgenic Mouse Model and Human Samples*

Tai, L. M., Bilousova, T., Jungbauer, L., Roeske, S. K., Youmans, K. L., Yu, C., Poon, W. W., Cornwell, L. B., Miller, C. A., Vinters, H. V., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442103 · Cited by 165 · see citing works

GLT-1 Loss Accelerates Cognitive Deficit Onset in an Alzheimer's Disease Animal Model

Mookherjee, P., Green, P. S., Watson, G. S., Marques, M. A., Tanaka, K., Meeker, K. D., Meabon, J. S., Li, N., Zhu, P., Olson, V. G., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110503 · Cited by 164 · see citing works

Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling

Guo, W., Qian, L., Zhang, J., Zhang, W., Morrison, A., Hayes, P. D., Wilson, S., Chen, T., & Zhao, J. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22725 · Cited by 162 · see citing works

Human brain myelination and amyloid beta deposition in Alzheimer's disease

Bartzokis, G., Lu, P. H., & Mintz, J. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.01.019 · Cited by 162 · see citing works

Binding of the Molecular Chaperone αB-Crystallin to Aβ Amyloid Fibrils Inhibits Fibril Elongation

Shammas, S. L., Waudby, C. A., Wang, S., Buell, A. K., Knowles, T. P. J., Ecroyd, H. W., Welland, M. E., Carver, J. A., Dobson, C. M., & Meehan, S. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.07.056 · Cited by 157 · see citing works

Amyloid β oligomers suppress excitatory transmitter release via presynaptic depletion of phosphatidylinositol-4,5-bisphosphate

He, Y., Wei, M., Wu, Y., Qin, H., Li, W., Ma, X., Cheng, J., Ren, J., Shen, Y., Chen, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09114-z · Cited by 156 · see citing works

Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ

Zhao, W.-Q., Lacor, P. N., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011015 · Cited by 154 · see citing works

The discovery of Alzheimer‐causing mutations in the <scp>APP</scp> gene and the formulation of the “amyloid cascade hypothesis”

Hardy, J. (2017) · The FEBS Journal · doi:10.1111/febs.14004 · Cited by 153 · see citing works

Direct Transcriptional Effects of Apolipoprotein E

Theendakara, V., Peters-Libeu, C. A., Spilman, P., Poksay, K. S., Bredesen, D. E., & Rao, R. V. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3562-15.2016 · Cited by 152 · see citing works

Spreading of amyloid-β peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance

Domert, J., Rao, S. B., Agholme, L., Brorsson, A., Marcusson, J. O., Hallbeck, M., & Nath, S. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.12.019 · Cited by 151 · see citing works

The most popular genes in the human genome

Dolgin, E. (2017) · Nature · doi:10.1038/d41586-017-07291-9 · Cited by 142 · see citing works

Extracellular vesicles derived from human Wharton’s jelly mesenchymal stem cells protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers

Bodart‐Santos, V., de Carvalho, L. R. P., de Godoy, M. A., Batista, A. F., Saraiva, L. M., Lima, L. G., Abreu, C. A., Felice, F. G. D., Galina, A., Méndez‐Otero, R., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1432-5 · Cited by 138 · see citing works

Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice

Ledo, J. H., Azevedo, E. P., Beckman, D., Ribeiro, F. C., Santos, L. E., Razolli, D. S., Kincheski, G. C., Melo, H. M., Bellio, M., Teixeira, A. L., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1269-16.2016 · Cited by 137 · see citing works

3D culture models of Alzheimer’s disease: a road map to a “cure-in-a-dish”

Choi, S. H., Kim, Y. H., Quinti, L., Tanzi, R. E., & Kim, D. Y. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0139-7 · Cited by 132 · see citing works

β-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology

Pike, C. J., Cummings, B. J., & Cotman, C. W. (1992) · Neuroreport · doi:10.1097/00001756-199209000-00012 · Cited by 131 · see citing works

Neurobiology of microglial action in CNS injuries: Receptor-mediated signaling mechanisms and functional roles

Hu, X., Liou, A. K. F., Leak, R. K., Xu, M., An, C., Suenaga, J., Shi, Y., Gao, Y., Zheng, P., & Chen, J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.002 · Cited by 131 · see citing works

Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms

Ting, J. T., Kelley, B. G., Lambert, T. J., Cook, D. G., & Sullivan, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608807104 · Cited by 129 · see citing works

Aging and amyloid β oligomers enhance TLR4 expression, LPS-induced Ca2+ responses, and neuron cell death in cultured rat hippocampal neurons

Calvo-Rodríguez, M., de la Fuente, C., García-Durillo, M., García‐Rodríguez, C., Villalobos, C., & Núñez, L. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0802-0 · Cited by 123 · see citing works

First CHO genome

Wurm, F. M., & Hacker, D. L. (2011) · Nature Biotechnology · doi:10.1038/nbt.1943 · Cited by 118 · see citing works

Signalling pathways leading to neuroblastoma differentiation after serum withdrawal: HDL blocks neuroblastoma differentiation by inhibition of EGFR

Evangelopoulos, M., Weis, J., & Krüttgen, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208494 · Cited by 115 · see citing works

P2Y1receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL‐6 release in hippocampal cultures

Fujita, T., Tozaki‐Saitoh, H., & Inoue, K. (2008) · Glia · doi:10.1002/glia.20749 · Cited by 113 · see citing works

Alzheimer's in 3D culture: Challenges and perspectives

D'Avanzo, C., Aronson, J., Kim, Y. H., Choi, S. H., Tanzi, R. E., & Kim, D. Y. (2015) · BioEssays · doi:10.1002/bies.201500063 · Cited by 111 · see citing works

Glycosylation and Fc Receptors

Hayes, J. M., Cosgrave, E. F. J., Struwe, W. B., Wormald, M., Davey, G. P., Jefferis, R., & Rudd, P. M. (2014) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-07911-0_8 · Cited by 110 · see citing works

A Novel Inhibitor of Amyloid β (Aβ) Peptide Aggregation

McKoy, A. F., Chen, J., Schüpbach, T., & Hecht, M. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348037 · Cited by 109 · see citing works

β-amyloid and ATP-induced diffusional trapping of astrocyte and neuronal metabotropic glutamate type-5 receptors

Shrivastava, A. N., Kowalewski, J. M., Renner, M. L., Bousset, L., Koulakoff, A., Melki, R., Giaume, C., & Triller, A. (2013) · Glia · doi:10.1002/glia.22548 · Cited by 107 · see citing works

Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage

Narayan, P. S., Holmström, K. M., Kim, D.-H., Whitcomb, D. J., Wilson, M. R., George‐Hyslop, P. S., Wood, N. W., Dobson, C. M., Cho, K., Abramov, A. Y., et al. (2014) · Biochemistry · doi:10.1021/bi401606f · Cited by 104 · see citing works

Neuroprotective Sirtuin ratio reversed by ApoE4

Theendakara, V., Patent, A., Peters Libeu, C. A., Philpot, B., Flores, S., Descamps, O., Poksay, K. S., Zhang, Q., Cailing, G., Hart, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314145110 · Cited by 101 · see citing works

β-Amyloid (Aβ) Oligomers Impair Brain-derived Neurotrophic Factor Retrograde Trafficking by Down-regulating Ubiquitin C-terminal Hydrolase, UCH-L1

Poon, W. W., Carlos, A. J., Aguilar, B. L., Berchtold, N. C., Kawano, C. K., Zograbyan, V., Yaopruke, T., Shelanski, M. L., & Cotman, C. W. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463711 · Cited by 100 · see citing works

An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies

Ryan, D. A., Narrow, W. C., Federoff, H. J., & Bowers, W. J. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.05.001 · Cited by 97 · see citing works

Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity

Welzel, A. T., Maggio, J. E., Shankar, G. M., Walker, D., Ostaszewski, B. L., Li, S., Klyubin, I. V., Rowan, M. J., Seubert, P. A., Walsh, D. M., et al. (2014) · Biochemistry · doi:10.1021/bi5003053 · Cited by 97 · see citing works

Aβ Oligomers Induce Glutamate Release from Hippocampal Neurons

Brito‐Moreira, J., Paula-Lima, A. C., Bomfim, T. R., de Oliveira, F. F., Sepúlveda, F. J., Mello, F. G. D., Aguayo, L. G., Panizzutti, R., & Ferreira, S. T. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391917 · Cited by 95 · see citing works

Efficient derivation of cortical glutamatergic neurons from human pluripotent stem cells: A model system to study neurotoxicity in Alzheimer's disease

Vazin, T., Ball, K. A., Lü, H., Park, H., Ataeijannati, Y., Head-Gordon, T. L., Poo, M., & Schaffer, D. V. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.005 · Cited by 91 · see citing works

N‐methyl‐D‐aspartate receptor–mediated calcium influx connects amyloid‐β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease

Kodis, E. J., Choi, S. H., Swanson, E., Ferreira, G., & Bloom, G. S. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.05.017 · Cited by 91 · see citing works

Amyloid-β Oligomers Induce Differential Gene Expression in Adult Human Brain Slices

Sebollela, A. S., Freitas-Corrêa, L., de Oliveira, F. F., Paula-Lima, A. C., Saraiva, L. M., Martins, S. M., Mota, L. D. C., Torres, C., Alves‐Leon, S. V., de Souza, J. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298471 · Cited by 86 · see citing works

Neuroprotective astrocyte-derived insulin/insulin-like growth factor 1 stimulates endocytic processing and extracellular release of neuron-bound Aβ oligomers

Pitt, J. E., Wilcox, K. C., Tortelli, V., Diniz, L. P., Oliveira, M. S., Dobbins, C., Yu, X., Nandamuri, S., Gomes, F. C. A., DiNunno, N., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-06-0416 · Cited by 86 · see citing works

EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers

Vargas, L. M., Leal, N. R., Estrada, L. D., González, A., Serrano, F. G., Araya, K. A., Gysling, K., Inestrosa, N. C., Pasquale, E. B., & Alvarez, A. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092309 · Cited by 85 · see citing works

Soluble Prion Protein Inhibits Amyloid-β (Aβ) Fibrillization and Toxicity

Nieznański, K., Choi, J.-K., Chen, S., Surewicz, K. A., & Surewicz, W. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.400614 · Cited by 85 · see citing works

Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β

Park, H., Kam, T., Kim, Y., Choi, H., Gwon, Y., Kim, C., Koh, J., & Jung, Y. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds100 · Cited by 85 · see citing works

Interaction of amyloid‐β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice

Brito-Moreira, J., Lourenco, M. V., Oliveira, M. M., Ribeiro, F. C., Ledo, J. H., Diniz, L. P., Vital, J. F. S., Magdesian, M. H., Melo, H. M., Barros-Aragão, F., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.761189 · Cited by 84 · see citing works

Amyloid β1–42 oligomer inhibits myelin sheet formation in vitro

Horiuchi, M., Maezawa, I., Itoh, A., Wakayama, K., Jin, L., Itoh, T., & DeCarli, C. S. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.007 · Cited by 83 · see citing works

The importance of the excitatory amino acid transporter 3 (EAAT3)

Bjørn-Yoshimoto, W. E., & Underhill, S. M. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.05.007 · Cited by 83 · see citing works

Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation

Filograna, R., Civiero, L., Ferrari, V., Codolo, G., Greggio, E., Bubacco, L., Beltramini, M., & Bisaglia, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136769 · Cited by 82 · see citing works

Amyloid β‐induced astrogliosis is mediated by β1‐integrin via NADPH oxidase 2 in Alzheimer's disease

Wyssenbach, A., Quintela‐López, T., Llavero, F., Zugaza, J. L., Matute, C., & Alberdi, E. M. (2016) · Aging Cell · doi:10.1111/acel.12521 · Cited by 81 · see citing works

Hippocampal GABAergic Neurons are Susceptible to Amyloid-β Toxicity in vitro and are Decreased in Number in the Alzheimer's Disease TgCRND8 Mouse Model

Krantic, S., Isorce, N., Mechawar, N., Davoli, M. A., Vignault, E., Albuquerque, M., Chabot, J.-G., Moyse, E., Chauvin, J.-P., Aubert, I., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110830 · Cited by 78 · see citing works

An Alzheimer's disease‐relevant presenilin‐1 mutation augments amyloid‐beta‐induced oligodendrocyte dysfunction

Desai, M. K., Guercio, B. J., Narrow, W. C., & Bowers, W. J. (2011) · Glia · doi:10.1002/glia.21131 · Cited by 74 · see citing works

Prion-like seeding and nucleation of intracellular amyloid-β

Olsson, T. T., Klementieva, O. L., & Gouras, G. K. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.01.015 · Cited by 72 · see citing works

Retrograde transport of neurotrophic factor signaling: implications in neuronal development and pathogenesis

Ito, K., & Enomoto, H. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw037 · Cited by 70 · see citing works

Apolipoprotein E3 (ApoE3) but Not ApoE4 Protects against Synaptic Loss through Increased Expression of Protein Kinase Cϵ

Sen, A., Alkon, D. L., & Nelson, T. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.312710 · Cited by 69 · see citing works

Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons

da Silva, G. S. S., Melo, H. M., Lourenco, M. V., Silva, N. M. L. E., de Carvalho, M. B., Alves‐Leon, S. V., de Souza, J. M., Klein, W. L., da‐Silva, W. S., Ferreira, S. T., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.753525 · Cited by 67 · see citing works

Treatment of Alzheimer’s Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future Directions

Ashford, J. W. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150381 · Cited by 66 · see citing works

APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression

Grimm, M. O. W., Mett, J., Stahlmann, C. P., Grösgen, S., Haupenthal, V. J., Blümel, T., Hundsdörfer, B., Zimmer, V. C., Mylonas, N. T., Tanila, H., et al. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00077 · Cited by 65 · see citing works

Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons

Umeda, T., Ramser, E. M., Yamashita, M., Nakajima, K., Mori, H., Silverman, M. A., & Tomiyama, T. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0230-2 · Cited by 63 · see citing works

Amyloid-β oligomers regulate the properties of human neural stem cells through GSK-3β signaling

Lee, I.-S., Jung, K., Kim, I., & Park, K. I. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.125 · Cited by 62 · see citing works

Quantification of [ 11 C]PIB PET for Imaging Myelin in the Human Brain: A Test—Retest Reproducibility Study in High-Resolution Research Tomography

Veronese, M., Bodini, B., García-Lorenzo, D., Battaglini, M., Bongarzone, S., Comtat, C., Bottlaender, M., Stankoff, B., & Turkheimer, F. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.120 · Cited by 60 · see citing works

Neuroblastoma Cell Lines-A Versatile in Vztro Model in Neurobiology

Shastry, P., Basu, A., & Rajadhyaksha, M. S. (2001) · International Journal of Neuroscience · doi:10.3109/00207450108986509 · Cited by 59 · see citing works

ApoE isoforms differentially regulates cleavage and secretion of BDNF

Sen, A., Nelson, T. J., & Alkon, D. L. (2017) · Molecular Brain · doi:10.1186/s13041-017-0301-3 · Cited by 59 · see citing works

Functional Interactions of Fibrillar and Oligomeric Amyloid-β with Alpha7 Nicotinic Receptors in Alzheimer's Disease

Lilja, A. M., Porras, O., Storelli, E., Nordberg, A., & Marutle, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101242 · Cited by 57 · see citing works

Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity

Peters, C., Espinoza, M. P., Gallegos, S., Opazo, C., & Aguayo, L. G. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.019 · Cited by 56 · see citing works

Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload

Cascella, R., Evangelisti, E., Bigi, A., Becatti, M., Fiorillo, C., Stefani, M., Chiti, F., & Cecchi, C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170340 · Cited by 56 · see citing works

The Synaptic Protein Neuroligin-1 Interacts with the Amyloid β-Peptide. Is There a Role in Alzheimer’s Disease?

Dinamarca, M. C., Weinstein, D. B., Monasterio, O., & Inestrosa, N. C. (2011) · Biochemistry · doi:10.1021/bi201246t · Cited by 53 · see citing works

Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice

Mably, A. J., Liu, W., Donald, J. M. M., Dodart, J., Bard, F., Lemere, C. A., O’Nuallain, B., & Walsh, D. M. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.07.008 · Cited by 52 · see citing works

Selective Acetyl- and Butyrylcholinesterase Inhibitors Reduce Amyloid-β Ex Vivo Activation of Peripheral Chemo-cytokines From Alzheimer’s Disease Subjects: Exploring the Cholinergic Anti-inflammatory Pathway

Reale, M., Nicola, M. D., Velluto, L., D’Angelo, C., Costantini, E., Lahiri, D. K., Kamal, M. A., Yu, Q.-S., & Greig, N. H. (2014) · Current Alzheimer Research · doi:10.2174/1567205010666131212113218 · Cited by 51 · see citing works

Mass Spectrometric Characterization of Amyloid-β Species in the 7PA2 Cell Model of Alzheimer's Disease

Portelius, E., Olsson, M., Brinkmalm, G., Rüetschi, U., Mattsson, N., Andréasson, U., Gobom, J., Brinkmalm, A., Hölttä, M., Blennow, K., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120994 · Cited by 50 · see citing works

Aging Enables Ca2+ Overload and Apoptosis Induced by Amyloid-β Oligomers in Rat Hippocampal Neurons: Neuroprotection by Non-Steroidal Anti-Inflammatory Drugs and R-Flurbiprofen in Aging Neurons

Calvo-Rodríguez, M., García-Durillo, M., Villalobos, C., & Núñez, L. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151189 · Cited by 49 · see citing works

Amyloid-β impairs development of neuronal progenitor cells by oxidative mechanisms

Mazur‐Kolecka, B., Golabek, A. A., Nowicki, K., Flory, M. J., & Frackowiak, J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.006 · Cited by 48 · see citing works

Morphological and functional differentiation in BE(2)-M17 human neuroblastoma cells by treatment with Trans-retinoic acid

Andres, D. K., Keyser, B. M., Petrali, J. P., Benton, B. J., Hubbard, K., McNutt, P. M., & Ray, R. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-49 · Cited by 48 · see citing works

Amyloid Beta Peptides Block New Synapse Assembly by Nogo Receptor-Mediated Inhibition of T-Type Calcium Channels

Zhao, Y., Sivaji, S., Chiang, M. C., Ali, H., Zukowski, M., Ali, S. T., Kennedy, B., Sklyar, A., Cheng, A., Guo, Z., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.041 · Cited by 46 · see citing works

Inhibition of Poly(ADP-ribose) Polymerase-1 Enhances Gene Expression of Selected Sirtuins and APP Cleaving Enzymes in Amyloid Beta Cytotoxicity

Wencel, P. L., Lukiw, W. J., Strosznajder, J. B., & Strosznajder, R. P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0646-8 · Cited by 43 · see citing works

Amyloid-beta peptide decreases expression and function of glutamate transporters in nervous system cells

Tong, H., Zhang, X., Meng, X., Xu, P., Zou, X., & Qu, S. (2017) · The International Journal of Biochemistry &amp; Cell Biology · doi:10.1016/j.biocel.2017.01.017 · Cited by 42 · see citing works

Aβ production as consequence of cellular death of a human neuroblastoma overexpressing APP

Recuero, M., Serrano, E., Bullido, M. J., & Valdivieso, F. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.025 · Cited by 38 · see citing works

Cell-derived soluble oligomers of human amyloid-β peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons

Yang, T.-T., Hsu, C.-T., & Kuo, Y. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0311-0 · Cited by 37 · see citing works

Genetic Variants of GSK3B are Associated with Biomarkers for Alzheimer's Disease and Cognitive Function

Kettunen, P., Larsson, S. C., Holmgren, S., Olsson, S., Minthon, L., Zetterberg, H., Blennow, K., Nilsson, S., & Sjölander, A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142025 · Cited by 36 · see citing works

Slit modulates cerebrovascular inflammation and mediates neuroprotection against global cerebral ischemia

Altay, T., McLaughlin, B., Wu, J. Y., Park, T. S., & Gidday, J. M. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.028 · Cited by 36 · see citing works

A cell culture model for investigation of synapse influenceability: epigenetics, expression and function of gene targets important for synapse formation and preservation in SH-SY5Y neuroblastoma cells differentiated by retinoic acid

Jahn, K., Wieltsch, C., Blumer, N., Mehlich, M., Pathak, H., Khan, H. U., Hildebrandt, H., & Frieling, H. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1769-9 · Cited by 36 · see citing works

Astrocytic α7 Nicotinic Receptor Activation Inhibits Amyloid-β Aggregation by Upregulating Endogenous αB-crystallin through the PI3K/Akt Signaling Pathway

Ren, Z., Yang, M., Guan, Z.-Z., & Yu, W. (2018) · Current Alzheimer Research · doi:10.2174/1567205015666181022093359 · Cited by 36 · see citing works

GALECTIN-8 Is a Neuroprotective Factor in the Brain that Can Be Neutralized by Human Autoantibodies

Pardo, E., Barake, F., Godoy, J. A., Oyanadel, C., Espinoza, S., Metz, C., Retamal, C., Massardo, L., Tapia‐Rojas, C., Inestrosa, N. C., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1621-3 · Cited by 34 · see citing works

Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?

Benussi, L., Binetti, G. G., & Ghidoni, R. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00672 · Cited by 33 · see citing works

Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease

Meeker, K. D., Meabon, J. S., & Cook, D. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142304 · Cited by 32 · see citing works

Characterization of Mitochondrial Dysfunction in the 7PA2 Cell Model of Alzheimer's Disease

Jakovljevic, N. K., Magnifico, M. C., Arese, M., Meli, G., Forte, E., Lecci, A., Manca, A., Giuffrè, A., Mastronicola, D., Sarti, P., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130728 · Cited by 32 · see citing works

Cerebral dopamine neurotrophic factor alleviates Aβ 25-35 -induced endoplasmic reticulum stress and early synaptotoxicity in rat hippocampal cells

Zhou, W., Chang, L., Fang, Y., Du, Z., Li, Y., Song, Y., Hao, F., Lv, L., & Wu, Y. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.09.008 · Cited by 32 · see citing works

Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [11C]ABP688 PET imaging and ex vivo immunoblotting

Fang, X. T., Eriksson, J., Antoni, G., Yngve, U., Cato, L., Lannfelt, L., Sehlin, D., & Syvänen, S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.009 · Cited by 31 · see citing works

Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum.

Benedet, A. L., Milà-Alomà, M., Vrillon, A., Ashton, N. J., Pascoal, T. A., Lussier, F., Karikari, T. K., Hourregue, C., Cognat, E., Dumurgier, J., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.3671 · Cited by 638 · see citing works

Alzheimer's Disease: Treatment Strategies and Their Limitations.

Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 592 · see citing works

Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation

Di Benedetto, G., Burgaletto, C., Bellanca, C. M., Munafò, A., Bernardini, R., & Cantarella, G. (2022) · Cells · doi:10.3390/cells11172728 · Cited by 189 · see citing works

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery

Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants · doi:10.3390/antiox10091353 · Cited by 179 · see citing works

Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies

Pires, M., & Rego, A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010778 · Cited by 157 · see citing works

Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer’s disease

Kumar, A., Fontana, I. C., & Nordberg, A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15565 · Cited by 150 · see citing works

Curcumin and Its Derivatives as Theranostic Agents in Alzheimer’s Disease: The Implication of Nanotechnology

Shabbir, U., Rubab, M., Tyagi, A., & Oh, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010196 · Cited by 117 · see citing works

Staging of Alzheimer's disease: past, present, and future perspectives.

Therriault, J., Zimmer, E., Benedet, A., Pascoal, T., Gauthier, S., & Rosa-Neto, P. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.05.008 · Cited by 93 · see citing works

Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease

Yin, T., Liu, Y., Ji, W., Zhuang, J., Chen, X., Gong, B., Chu, J., Liang, W., Gao, J., & Yin, Y. (2023) · Theranostics · doi:10.7150/thno.81860 · Cited by 102 · see citing works

Synaptogenic effect of APP -Swedish mutation in familial Alzheimer’s disease

Zhou, B., Lu, J. G., Siddu, A., Wernig, M., & Südhof, T. C. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn9380 · Cited by 96 · see citing works

Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies

Buccellato, F. R., D’Anca, M., Tartaglia, G. M., Del Fabbro, M., Scarpini, E., & Galimberti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813900 · Cited by 94 · see citing works

The role of astrocytic α7 nicotinic acetylcholine receptors in Alzheimer disease

Fontana, I. C., Kumar, A., & Nordberg, A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00792-4 · Cited by 86 · see citing works

Potential neurotoxic activity of diverse molecules released by microglia

Lindhout, I. A., Murray, T. E., Richards, C. M., & Klegeris, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105117 · Cited by 56 · see citing works

Effects and mechanisms of natural products on Alzheimer’s disease

Yang, Z., Zhou, D.-D., Huang, S., Fang, A., Li, H., & Zhu, H. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1985428 · Cited by 59 · see citing works

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Yao, Y., Ren, Z., Yang, R., Mei, Y., Dai, Y., Cheng, Q., Xu, C., Xu, X., Wang, S., Kim, K. M., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00918-z · Cited by 52 · see citing works

Kaempferol as a potential neuroprotector in Alzheimer's disease

Nejabati, H. R., & Roshangar, L. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14375 · Cited by 46 · see citing works

Crosstalk between Oxidative Stress and Aging in Neurodegeneration Disorders

Abdelhamid, R. F., & Nagano, S. (2023) · Cells · doi:10.3390/cells12050753 · Cited by 40 · see citing works

Detrimental Effects of ApoE ε4 on Blood–Brain Barrier Integrity and Their Potential Implications on the Pathogenesis of Alzheimer’s Disease

Kirchner, K., Garvert, L., Kühn, A. L., Bonk, S., Grabe, H. J., & der Auwera, S. V. (2023) · Cells · doi:10.3390/cells12212512 · Cited by 39 · see citing works

Rhein Relieves Oxidative Stress in an Aβ1-42 Oligomer-Burdened Neuron Model by Activating the SIRT1/PGC-1α-Regulated Mitochondrial Biogenesis

Yin, Z., Geng, X., Zhang, Z., Wang, Y., & Gao, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.746711 · Cited by 40 · see citing works

The dense-core plaques of Alzheimer’s disease are granulomas

Lemke, G., & Huang, Y. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20212477 · Cited by 37 · see citing works

A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases

Fontana, I. C., de Souza, D. G., Souza, D. O., Gee, A. D., Zimmer, E. R., & Bongarzone, S. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01572 · Cited by 34 · see citing works

Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?

Ailioaie, L. M., Ailioaie, C., & Litscher, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030916 · Cited by 37 · see citing works

Effect of natural compounds on NRF2/KEAP1 signaling in periodontitis: a potential use to prevent age-related disorders

Tossetta, G., Fantone, S., Olivieri, F., Roberta Mazzucchelli, A., Togni, L., Santarelli, A., Marzioni, D., & Rippo, M. R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10878-5 · Cited by 31 · see citing works

Endothelial Senescence and Its Impact on Angiogenesis in Alzheimer’s Disease

Georgieva, I., Tchekalarova, J. D., Iliev, D. B., & Tzoneva, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411344 · Cited by 29 · see citing works

Cerebrospinal Fluid Neurotransmitters, Cytokines, and Chemokines in Alzheimer’s and Lewy Body Diseases

Lourenco, M. V., Ribeiro, F. C., Santos, L. E., Beckman, D., Melo, H. M., Sudo, F. K., Drummond, C., Assunção, N., Vanderborght, B., Tovar-Moll, F. F., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210147 · Cited by 27 · see citing works

Modeling Alzheimer’s disease using human cell derived brain organoids and 3D models

Fernandes, S., Revanna, J. S., Pratt, J. M., Hayes, N., Marchetto, M. C., & Gage, F. H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1434945 · Cited by 29 · see citing works

The Different Faces of the TDP-43 Low-Complexity Domain: The Formation of Liquid Droplets and Amyloid Fibrils

Chien, H.-M., Lee, C.-C., & Huang, J. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158213 · Cited by 23 · see citing works

Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer’s disease but not Lewy body dementias

Chai, Y. L., Lee, J. H., Chong, J. R., Ballard, C. G., Francis, P. T., Kennedy, B. K., Arumugam, T. V., Chen, C., Aarsland, D., & Lai, M. K. P. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02789-8 · Cited by 23 · see citing works

Mitochondrial Disruption by Amyloid Beta 42 Identified by Proteomics and Pathway Mapping

Sinclair, P., Baranova, A. V., & Kabbani, N. (2021) · Cells · doi:10.3390/cells10092380 · Cited by 22 · see citing works

Immortalized Alzheimer’s Disease Astrocytes: Characterization of Their Proteolytic Systems

Gong, C., Bonfili, L., Zheng, Y., Cecarini, V., Cuccioloni, M., Angeletti, M., Dematteis, G., Tapella, L., Genazzani, A. A., Lim, D., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03231-z · Cited by 22 · see citing works

Nicotine prevents in vivo Aβ toxicity in Caenorhabditis elegans via SKN-1

Lu, X., Zhang, Y., Li, H., Jin, Y., Zhao, L., & Wang, X. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136114 · Cited by 21 · see citing works

Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging Perspective

Fontana, I., Scarpa, M., Malarte, M., Rocha, F. M., Ausellé-Bosch, S., Bluma, M., Bucci, M., Chiotis, K., Kumar, A., & Nordberg, A. (2023) · Cells · doi:10.3390/cells12111469 · Cited by 19 · see citing works

Impact of New Drugs for Therapeutic Intervention in Alzheimer’s Disease

Olloquequi, J., Ettcheto, M., Cano, A. C., Sánchez‐López, E., Carrasco, M., Espinosa-Jiménez, T., Beas‐Zárate, C., Gudiño‐Cabrera, G., Ureña‐Guerrero, M. E., Verdaguer, E., et al. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2705146 · Cited by 21 · see citing works

The Role of Oligodendrocytes in Neurodegenerative Diseases: Unwrapping the Layers

Panichi, L. B., Stanca, S., Dolciotti, C., & Bongioanni, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104623 · Cited by 20 · see citing works

Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics

Arar, S. H., Haque, M. A., & Kayed, R. (2023) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26561 · Cited by 19 · see citing works

Characterization of a Conformation-Restricted Amyloid β Peptide and Immunoreactivity of Its Antibody in Human AD brain

Kageyama, Y., Irie, Y., Matsushima, Y., Segawa, T., Bellier, J., Hidaka, K., Sugiyama, H., Kaneda, D., Hashizume, Y., Akatsu, H., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00416 · Cited by 19 · see citing works

Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers

Limbocker, R., Mannini, B., Cataldi, R., Chhangur, S., Wright, A. K., Kreiser, R. P., Albright, J. A., Chia, S., Habchi, J., Sormanni, P., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124542 · Cited by 18 · see citing works

Neuroprotective Effect of NO-Delivery Dinitrosyl Iron Complexes (DNICs) on Amyloid Pathology in the Alzheimer’s Disease Cell Model

Chuang, W.-H., Chou, Y.-T., Chen, Y.-H., Kuo, T.-H., Liaw, W., Lu, T., Kao, C.-F., & Wang, Y. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00348 · Cited by 17 · see citing works

Abl depletion via autophagy mediates the beneficial effects of quercetin against Alzheimer pathology across species

Schiavi, A., Cirotti, C., Gerber, L., Lauro, G. D., Maglioni, S., Shibao, P. Y. T., Montresor, S., Kirstein, J., Petzsch, P., Köhrer, K., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01592-x · Cited by 16 · see citing works

MiR-7a–Klf4 axis as a regulator and therapeutic target of neuroinflammation and ferroptosis in Alzheimer’s disease

Ramesh, M., & Govindaraju, T. (2025) · NAR Molecular Medicine · doi:10.1093/narmme/ugaf022 · Cited by 14 · see citing works

In vitro electrochemical detection of the degradation of amyloid-β oligomers

Zhang, B., Zhu, T., Liu, L., & Yuan, L. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.09.009 · Cited by 14 · see citing works

Tau, amyloid, iron, oligodendrocytes ferroptosis, and inflammaging in the hippocampal formation of aged rats submitted to an aerobic exercise program

Gutierre, R. C., Rocha, P. R. M., Graciani, A. L., Ribeiro, A. A. C. M., & Arida, R. M. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149419 · Cited by 14 · see citing works

9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model

Ju, Y., & Tam, K. Y. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108354 · Cited by 13 · see citing works

Metal nanocomposites for biosensing amyloid beta peptides: Advancing point-of-care diagnostics in Alzheimer's disease

Natarajan, B., Zhou, Q., Maduraiveeran, G., & Kannan, P. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.217682 · Cited by 12 · see citing works

Oligomeric Amyloid-β and Tau Alter Cell Adhesion Properties and Induce Inflammatory Responses in Cerebral Endothelial Cells Through the RhoA/ROCK Pathway

Hossen, F., Geng, X. H., Sun, G. Y., Yao, X., & Lee, J. C. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04138-z · Cited by 12 · see citing works

1,3,5-Triazine: A Promising Molecular Scaffold for Novel Agents for the Treatment of Alzheimer’s Disease

Silva, C. F. M., Guerrinha, A. P. D. D. M. S., Carvalho, S., Pinto, D. C. G. A., & Silva, A. M. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030882 · Cited by 12 · see citing works

Spatial sequestration of misfolded proteins in neurodegenerative diseases

Rolli, S., & Sontag, E. M. (2022) · Biochemical Society Transactions · doi:10.1042/bst20210862 · Cited by 13 · see citing works

Estradiol Prevents Amyloid Beta-Induced Mitochondrial Dysfunction and Neurotoxicity in Alzheimer’s Disease via AMPK-Dependent Suppression of NF-κB Signaling

Mishra, P., Esfahani, E., Fernyhough, P., & Albensi, B. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136203 · Cited by 11 · see citing works

Profiling of long non-coding RNAs in hippocampal–entorhinal system subfields: impact of RN7SL1 on neuroimmune response modulation in Alzheimer’s disease

Liu, H., Li, J., Wang, X., Luo, S., Luo, D., Ge, W., & Ma, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03083-x · Cited by 9 · see citing works

Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier

Takeuchi, L. E., Kalia, L. V., & Simmons, C. A. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106864 · Cited by 11 · see citing works

Fiscalin Derivatives as Potential Neuroprotective Agents

Barreiro, S., Silva, B., Long, S., Pinto, M. M. M., Remião, F., Sousa, E., & Silva, R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071456 · Cited by 9 · see citing works

Brain-targeting liposome-based APOE2 gene delivery exacerbates soluble amyloid-β accumulation in AppNL−G-F mice

Wang, N., Parsons, T. M., Ren, Y., Pan, Y., Kurti, A., Starling, S. C., Muolokwu, C. E., Singh, J., & Kanekiyo, T. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39607 · Cited by 9 · see citing works

Insulin signaling in microglia: A metabolic switch controlling neuroinflammation and amyloid pathology in Alzheimer’s disease

Barone, E., & Butterfield, D. A. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.06.005 · Cited by 9 · see citing works

ERp57 chaperon protein protects neuronal cells from Aβ‐induced toxicity

Risola, D. D., Ricci, D., Marrocco, I., Giamogante, F., Grieco, M., Francioso, A., Vasco, A. V., Mancini, P., Colotti, G., Mosca, L., et al. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15655 · Cited by 8 · see citing works

Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular, and Alzheimer’s diseases

Pires, E. N. S., Ferreira, S. T., & Linden, R. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15129 · Cited by 9 · see citing works

The Co-oligomers of Aβ42 and Human Islet Amyloid Polypeptide Exacerbate Neurotoxicity and Alzheimer-like Pathology at Cellular Level

Deng, J., Liu, B., Tao, Q., Luo, Y., Zhu, Y., Huang, X., & Yue, F. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.04.002 · Cited by 8 · see citing works

How Salt and Temperature Drive Reentrant Condensation of Aβ40

Sarkar, S., & Mondal, J. (2024) · Biochemistry · doi:10.1021/acs.biochem.4c00412 · Cited by 8 · see citing works

Quantum dots in neurotheranostics for the treatment of Alzheimer’s disease

Sharma, T., Bashir, B., Sharma, P., andotra, N., Singh, S. K., Singh, T. G., & Vishwas, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102876 · Cited by 9 · see citing works

Nicotinic receptor components of amyloid beta 42 proteome regulation in human neural cells

Sinclair, P., & Kabbani, N. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270479 · Cited by 8 · see citing works

Rapid size-exclusion high performance liquid chromatography method for the quality control of amyloid-β oligomers

Fontana, I. C., Ferreira, P. C. L., Miron, D., Santos, L. E., Ferreira, S. T., Souza, D. O., Gosmann, G., Zimmer, E. R., & Zimmer, A. R. (2021) · Journal of Chromatography A · doi:10.1016/j.chroma.2021.462024 · Cited by 8 · see citing works

Oligomeric and Fibrillar Species of Aβ42 Diversely Affect Human Neural Stem Cells

Bernabeu-Zornoza, A., Coronel, R., Palmer, C., López-Alonso, V., & Liste, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179537 · Cited by 8 · see citing works

Using stable isotope labeling to advance our understanding of Alzheimer’s disease etiology and pathology

Hark, T. J., & Savas, J. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15298 · Cited by 7 · see citing works

Emerging concepts towards a translational framework in Alzheimer’s disease

Cozachenco, D., Zimmer, E. R., & Lourenco, M. V. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105246 · Cited by 7 · see citing works

Tinosinenside A inhibits neuroinflammation and protects HT22 cells by suppressing the TLR4/NF-κB/NLRP3 signaling pathway in BV2 cells

Xie, Y., Qin, Y., Wang, J., Xu, Z., Chen, L., Kuang, Y., Yang, R., & Huang, L. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03828-2 · Cited by 6 · see citing works

Precision Medicine in Neurodegenerative Diseases: Genomic Approaches to Target Amyloid-β, Tau, and Alpha-Synuclein Pathways

Waqar, Z., Sethi, P., Jain, D., Singh, K., Alsaidan, O. A., Alzarea, S. I., Gupta, J. K., Saxena, S., & Sharma, M. C. (2025) · Current Genomics · doi:10.2174/0113892029372437251010114053 · Cited by 5 · see citing works

The effect of human PBMCs immobilization on their Аβ42 aggregates-dependent proinflammatory state on a cellular model of Alzheimer’s disease

Kot, K., Kot, Y. G., Kurbanov, R., Андріяш, Г. С., Tigunova, O., Blume, Y. B., & Shulga, S. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1325287 · Cited by 5 · see citing works

Therapeutic effects of a novel synthetic α-secretase

Kim, S. B., Mun, B.-R., Kim, S. Y., Elangovan, M., Park, E. J., Choi, W., & Park, W. J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1383905 · Cited by 5 · see citing works

Modelling sex differences of neurological disorders in vitro

Castro‐Aldrete, L., Einsiedler, M., Cuní‐López, C., Vanhaelen, Q., Silvestri, A., Ferretti, M. T., de Gennaro, M. E., Putignano, G., Guix, M., Marino, N., et al. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00355-w · Cited by 4 · see citing works

From protective enzyme to facilitator of amyloid propagation: Cathepsin D-mediated amyloid fibril fragmentation

Sulatsky, M. I., Stepanenko, O. V., Stepanenko, O. V., Mikhailova, E. V., & Sulatskaya, A. I. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140971 · Cited by 4 · see citing works

Dual Efficacy of a Catalytic Anti-Oligomeric Aβ42 scFv Antibody in Clearing Aβ42 Aggregates and Reducing Aβ Burden in the Brains of Alzheimer’s Disease Mice

Song, C., Li, H., Zheng, C., Zhang, T., & Zhang, Y. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03406-8 · Cited by 4 · see citing works

Discovery of novel coumarin triazolyl and phenoxyphenyl triazolyl derivatives targeting amyloid beta aggregation-mediated oxidative stress and neuroinflammation for enhanced neuroprotection

Visansirikul, S., Yanaso, S., Boondam, Y., Prasittisa, K., Prutthiwanasan, B., Chongruchiroj, S., & Sripha, K. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00270a · Cited by 4 · see citing works

Degradation of pathogenic amyloids induced by matrix metalloproteinase-9.

Stepanenko, O., Sulatsky, M., Mikhailova, E. V., Stepanenko, O., & Sulatskaya, A. I. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136362 · Cited by 4 · see citing works

Antiproliferative and apoptotic effects of Pervari honey on SH-SY5Y neuroblastoma cells

Çelik, P. A., Derya-Andeden, M., Eci̇roglu, H., & Dönmez‐Altuntaş, H. (2025) · Medical Oncology · doi:10.1007/s12032-025-02963-3 · Cited by 2 · see citing works

Molecular recognition of amyloid-β oligomers in Alzheimer's disease

Jehangir, M., Xia, X., Wang, C., Hu, M., & Wang, X. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.115298 · Cited by 2 · see citing works

Analyzing Nicotine Action Against Amyloid Toxicity by NMR‐Pharmacometabolomics: An Exploratory Study

Napolitano, E., Marino, C., Grimaldi, M., Buonocore, M., Santoro, A., & D’Ursi, A. M. (2026) · NMR in Biomedicine · doi:10.1002/nbm.70255 · Cited by 2 · see citing works

Limitations and Strengths of the SH ‐ SY5Y Neuroblastoma Cell Line as a Model of β‐Amyloid Neurotoxicity: Lessons From a Systematic Review and Meta‐Analysis

Pinheiro, N. R., Carneiro, C. F. D., Cancelliero, G. S., Nogueira, G. O., de Almeida, G. M., Fernandes, N., Wasilewska‐Sampaio, A. P., Martins, S. M., Filho, A. F. D. S., Amaral, O. B., et al. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70523 · Cited by 6 · see citing works

The current models unravel the molecular mechanisms underlying the intricate pathophysiology of Alzheimer's disease using zebrafish

Thawkar, B. S., & Kaur, G. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.03.009 · Cited by 2 · see citing works

Microenvironment Drives Reentrant Condensation of Aβ40Preprint

Sarkar, S., & Mondal, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.27.591429 · Cited by 2 · see citing works

The human neuroblastoma SH-SY5Y cell line as a model to assess β-amyloid neurotoxicity: A systematic review and meta-analysisPreprint

Pinheiro, N. R., Carneiro, C. F. D., Cancelliero, G. S., Nogueira, G. O., de Almeida, G. M., Fernandes, N. R. D. S., Wasilewska‐Sampaio, A. P., Martins, S. M., Filho, A. F. D. S., Amaral, O. B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.20.683497 · Cited by 2 · see citing works

In Situ 3D SERS Imaging of CO 2 Reduction in Living Cells

Gong, T., Chen, H., Fan, R. Y., Zhang, X., Yong, K., & Kong, K. V. (2025) · Small · doi:10.1002/smll.202410250 · Cited by 1 · see citing works

Preexisting Genetic Background Primes the Responses of Human Neurons to Amyloid β

Soladogun, A. S., & Li, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199804 · Cited by 1 · see citing works

Protein disulfide isomerase dissolves and detoxifies oligomeric assemblies of amyloid beta peptide

Mele, A., Serrano, A., Zabala-Rodriguez, M. C., Evangelista, B., Lehew, H., Kovacevic, J., Taylor, M. D., Tatulian, S. A., & Teter, K. (2026) · FEBS Letters · doi:10.1002/1873-3468.70311 · Cited by 1 · see citing works

The mitochondria-synapse axis in Alzheimer’s disease: Lost coordination in early stages

Sharma, P., Kaur, N., Vasal, N., Solanki, K., & Sunkaria, A. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103168 · Cited by 1 · see citing works

In vitro cell-line models of Alzheimer’s disease: A systematic review and mechanism-based evidence map of induction paradigms, targeted mechanisms, and validation requirements

Alghamdi, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103322 · Cited by 1 · see citing works

Scientific Evidence of Baduanjin Improving Cognitive Function in Patients with Cognitive Impairment

唐, 琼. (2024) · Open Journal of Natural Science · doi:10.12677/ojns.2024.122032 · Cited by 1 · see citing works

Amyloid β fragments that suppress oligomers but not fibrils are cytoprotective

Zabala-Rodriguez, M. C., Teter, K., & Tatulian, S. A. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110386 · Cited by 1 · see citing works

Entrevista a Adolfo Castañón

Serrano, S. (2006) · Cuadernos hispanoamericanos

INTERNATIONAL CONFERENCE ON STANDARDIZATION OF RADIATION SOURCES.

Sul'kin, A. G., & Chervatenko, G. A. (1968) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)

Alzheimer’s disease as a syndrome of overloaded amyloidic synaptic tagging in memory networksPreprint

Murphy, N. (2021) · doi:10.31219/osf.io/7gsaz

Development of medical polymers for applications in neurological disorders

Espinoza, F., Ide, W., Saldivia, N., & Zelada, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85233-3.00012-4

Neuroprotection induced by erythropoietin

Maltaneri, R. E., Chamorro, M. E., Nesse, A. B., & Vittori, D. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00059-2

Amyloid Β Fragments that Suppress Oligomers But Not Fibrils are CytoprotectivePreprint

Zabala-Rodriguez, M. C., Teter, K., & Tatulian, S. A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5120790

Fluidic Programmable Gravi-maze Array for High Throughput Multiorgan Drug TestingPreprint

Wong, H. C., Collins, C. J., Jose, J. A. J., Villegas, A. J., Bhakta, I. N., Collins, A. J., Katara, G., Kohana, J., Saluja, H. S., & Collins, J. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.18.660241

Dietary docosahexaenoic acid and dihydrocaffeic acid, a chlorogenic acid derivative, confer additive neuroprotection against β-amyloid in SH-SY5Y cells

Reza-Zaldívar, E. E., Faccinetto-Beltrán, P., & Jacobo‐Velázquez, D. A. (2025) · CyTA - Journal of Food · doi:10.1080/19476337.2025.2526636

Interacciones entre beta-amiloide y proteínas sinápticas en la modulación de neurogranina en la fase preclínica de la enfermedad de Alzheimer

Tirado, A. G. (2025) · Neurología Argentina · doi:10.1016/j.neuarg.2025.06.004

In vitro 3D models of neuron-astrocyte interactions

Su, T., Li, Z., Yang, Y., Dai, Y., Li, Y., & Zhao, H. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102400

Additional file 1 of Profiling of long non-coding RNAs in hippocampal–entorhinal system subfields: impact of RN7SL1 on neuroimmune response modulation in Alzheimer’s disease

Liu, H., Li, J., Wang, X., Luo, S., Luo, D., Ge, W., & Ma, C. (2024) · Figshare · doi:10.6084/m9.figshare.26703235

Additional file 2 of Profiling of long non-coding RNAs in hippocampal–entorhinal system subfields: impact of RN7SL1 on neuroimmune response modulation in Alzheimer’s disease

Liu, H., Li, J., Wang, X., Luo, S., Luo, D., Ge, W., & Ma, C. (2024) · Figshare · doi:10.6084/m9.figshare.26703238

Induced-pluripotent stem cell-derived immunotherapy for Tau and Alzheimer’s disease

Chinnathambi, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.005

Amphiphilic Tetraphenylethylene Derivative with Hydrophobic–Hydrophilic Complementarity to Amyloid Oligomers for in Situ Imaging and Modulation of Membrane-Disruptive Neurotoxicity

Chen, J., Tang, X., Hu, Y., Feng, H., Zhang, G., Zhang, D., Huang, Y., & Zhao, R. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c07117

Distinct types of amyloid‐β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease

Madhu, P., & Mukhopadhyay, S. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30141 · Cited by 50 · see citing works

The Toxicity and Polymorphism of β-Amyloid Oligomers

Huang, Y., & Liu, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124477 · Cited by 168 · see citing works

Operational dissection of β‐amyloid cytopathic effects on cultured neurons

Callizot, N., Combes, M., Steinschneider, R., & Poindron, P. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23193 · Cited by 29 · see citing works

Amyloid oligomers: formation and toxicity of Aβ oligomers

Sakono, M., & Zako, T. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07568.x · Cited by 602 · see citing works

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Mroczko, B., Groblewska, M., Litman-Zawadzka, A., Kornhuber, J., & Lewczuk, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071884 · Cited by 97 · see citing works